British American Tobacco plc Heading For 9% Growth

Forecasts indicate a return to earnings growth for British American Tobacco plc (LON: BATS)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Earnings growth at British American Tobacco (LSE: BATS) (NYSE: BTI.US) has been sliding over the past five years. Back in 2009, the purveyor of the deadly weed enjoyed a 19% rise in earnings per share (EPS), but since then the annual rise has slowed as far as last year’s 5% — and there’s a small fall of 1% forecast for the year to December 2014.

british american tobacco / imperial tobaccoDividend growth has been slowing too, from the days of 14% growth in 2010 to 5.6% in 2013, although that is not expected to turn negative along with earnings. In fact, there’s still a dividend boost of 3.8% forecast for this year, to take the payout to 147p and provide a yield of 4.3% on a 3,464p share price.

2015 reversal

And expectations for 2015 are currently indicating a reversal of recent fortunes — we have a 9% EPS rise penciled in, together with a 7% hike in the dividend to take the yield up to 4.6%.

These predictions are way down on the analysts’ positions 12 months ago, mind — back then the consensus suggested EPS of 251p for 2014 with a dividend of 164p, and it’s a big drop to the latest 215p and 147p respectively.

Share price picking up

The share price has been falling for much of the past year too, and early in 2014 it had dropped around 20% — but we’ve since seen a recovery to take us back to a modest 5% slip over 12 months.

The problems for the tobacco business are well known — people are simply smoking less, and stick volumes at British American and rival Imperial Tobacco have been steadily falling year-on-year. But a switch in focus towards premium-priced brands has helped keep earnings rising, albeit at a slower pace.

Surprisingly popular

That, the healthy nature of the dividends (if not the companies’ products), coupled with the largely defensive nature of the business as an investment, has helped keep the punters bullish on British American shares.

In fact, out of a sample of 23 analysts, 13 rate the shares a Buy or a Strong Buy, with only two thinking we should sell the shares — the remaining eight are sticking with a Hold stance.

Not for the long term

Are the commentators right and should we buy British American Tobacco? Well, the City does tend to have a short-term outlook, and with a forward P/E of 16 for this year dropping to 14.5 for 2015, the shares are not overvalued in the short term.

But if you have a 10 or 20-year horizon, there are surely better places for your investment cash than a declining industry.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Alan does not own any shares in British American Tobacco.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »